News updates

More reports of liver toxicity with Ashwagandha

In September 2023, the Netherlands Pharmacovigilance centre Lareb warned of liver toxicity in people using products containing ashwagandha. Sin...

Illegal addition of medication to herbal supplement Montalin once again

Users of the herbal supplement Montalin may unknowingly ingest a corticosteroid. This can lead to unintended and potent...

COVID-19 vaccination during pregnancy and neonatal health

Using data from the Dutch Pregnancy Drug Register, Netherlands Pharmacovigilance Centre Lareb found no association between COVID-19 v...

Nerve damage due to the use of nutritional supplements with vitamin B6

The Netherlands Pharmacovigilance Centre Lareb has previously reported on nerve damage caused by the use of nutritional ...

MedSafetyWeek 2024

Today, the MedSafetyWeek starts. The MedSafetyWeek is an annual (social) media campaign focussing on raising awareness of pharmacovigilance, and promoting recognition and r...

Fever and mebendazole

Until July 2024, the Netherlands Pharmacovigilance Centre Lareb received 23 reports of fever following use of mebendazole. Fever is not a known side effect of mebendazol...

Highlighting challenges in monitoring herbal products and presenting universal recommendations

Lareb conducted a study comprised of semi-structured interviews in order to explore the current ...

Prolonged duration of COVID-19 vaccine-induced lymphadenopathy

The Netherlands Pharmacovigilance Centre Lareb has received reports of enlarged lymph nodes after COVID-19 vaccination that do n...

Possible ischaemic colitis after bisacodyl use

The Netherlands Pharmacovigilance Centre Lareb received two reports of ischaemic colitis after bisacodyl use. Ischaemic colitis often resolves s...